CD274 and hepatocellular carcinoma: Liu [37] prepared nanobubbles for loading programmed death ligand 1 (PD-L1) antibody and the miR-424 gene, which significantly enhanced the immunotherapy effect of hepatocellular carcinoma and improved anti-tumor effects.